Target intelligence / Profile preview

DNA-topoisomerase I complex (Top1cc)

Target
Top1cc
Molecular classification
Enzyme, DNA-protein complex, Isomerase
01

Overview

The DNA-topoisomerase I complex is a transient, covalent intermediate formed during the catalytic cycle of the topoisomerase I (TOP1) enzyme. TOP1 is a critical nuclear enzyme that relieves torsional strain in DNA by creating reversible single-strand breaks, allowing the DNA to rotate and relax during replication and transcription (Pommier, 2006, Nature Reviews Cancer; UniProt P11387). During this process, the enzyme becomes covalently linked to the 3'-phosphate end of the DNA, forming what is known as the Top1-DNA cleavage complex (Top1cc) (Thomas et al., 2004, Chemical Reviews). This complex is the specific molecular target for camptothecin-based drugs and their derivatives, which act as topoisomerase poisons by binding at the enzyme-DNA interface (Pommier, 2013, Nature Reviews Cancer). By stabilizing the Top1cc, these drugs prevent the religation of the DNA strand, effectively trapping the enzyme on the DNA. When advancing replication forks or transcription complexes collide with these trapped Top1cc units, they generate lethal double-strand breaks that trigger apoptosis (Murai et al., 2012, Cell Reports). Clinically, targeting this complex is a cornerstone in the treatment of various malignancies, including colorectal, lung, and ovarian cancers.

Other names
DNA and DNA–topoisomerase I complexTopoisomerase I-DNA cleavage complexTop1-DNA complexDNA-topoisomerase I covalent complexTOP1-DNA cleavage complex
02

Mechanism of action

Stabilization of the covalent DNA-topoisomerase I cleavage complex (interfacial inhibition), preventing DNA religation and causing replication-mediated double-strand breaks.

03

Biological functions

DNA replicationTranscriptionDNA repairChromatin remodelingRelief of DNA torsional strain
04

Disease associations

Cancer
05

Safety considerations

MyelosuppressionSevere diarrheaNeutropeniaGastrointestinal toxicity
06

Interacting drugs

Irinotecan

7 more in the full profile.

07

Biomarkers

Topoisomerase I (TOP1) expressionSchlafen 11 (SLFN11) expressionGamma-H2AX (DNA damage marker)

Beyond the preview

Go deeper on DNA-topoisomerase I complex (Top1cc).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA-topoisomerase I complex (Top1cc).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call